<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>〈鱗癌〉彙整頁面 - willnews分享應該關心的新聞</title>
	<atom:link href="https://will-news.info/tag/%E9%B1%97%E7%99%8C/feed/" rel="self" type="application/rss+xml" />
	<link>https://will-news.info/tag/鱗癌/</link>
	<description></description>
	<lastBuildDate>Thu, 06 Jun 2019 10:04:57 +0000</lastBuildDate>
	<language>zh-TW</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.4</generator>

<image>
	<url>https://i0.wp.com/will-news.info/wp-content/uploads/2019/06/cropped-13415475.jpg?fit=32%2C32&#038;ssl=1</url>
	<title>〈鱗癌〉彙整頁面 - willnews分享應該關心的新聞</title>
	<link>https://will-news.info/tag/鱗癌/</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">158620384</site>	<item>
		<title>肺鱗狀癌標靶藥納健保 患者續命新希望</title>
		<link>https://will-news.info/2019/06/06/%e8%82%ba%e9%b1%97%e7%8b%80%e7%99%8c%e6%a8%99%e9%9d%b6%e8%97%a5%e7%b4%8d%e5%81%a5%e4%bf%9d-%e6%82%a3%e8%80%85%e7%ba%8c%e5%91%bd%e6%96%b0%e5%b8%8c%e6%9c%9b/</link>
		
		<dc:creator><![CDATA[will新聞]]></dc:creator>
		<pubDate>Thu, 06 Jun 2019 10:04:57 +0000</pubDate>
				<category><![CDATA[癌症新聞]]></category>
		<category><![CDATA[肺癌]]></category>
		<category><![CDATA[鱗癌]]></category>
		<guid isPermaLink="false">https://will-news.info/2019/06/06/%e8%82%ba%e9%b1%97%e7%8b%80%e7%99%8c%e6%a8%99%e9%9d%b6%e8%97%a5%e7%b4%8d%e5%81%a5%e4%bf%9d-%e6%82%a3%e8%80%85%e7%ba%8c%e5%91%bd%e6%96%b0%e5%b8%8c%e6%9c%9b/</guid>

					<description><![CDATA[<p>肺癌是國人十大癌症死因第一位，種類分為肺鱗癌與肺腺癌，根據統計，台灣每年新增1萬3000多名肺癌患者中，近2000人為肺鱗癌，但肺麟癌的治療選擇較少，僅有少數患者可存活超過一年；健保署六月起納入一款治療肺麟癌的不可逆標靶藥物，副作用較化療小，可有助提升患者存活期。</p>
<p>〈<a href="https://will-news.info/2019/06/06/%e8%82%ba%e9%b1%97%e7%8b%80%e7%99%8c%e6%a8%99%e9%9d%b6%e8%97%a5%e7%b4%8d%e5%81%a5%e4%bf%9d-%e6%82%a3%e8%80%85%e7%ba%8c%e5%91%bd%e6%96%b0%e5%b8%8c%e6%9c%9b/">肺鱗狀癌標靶藥納健保 患者續命新希望</a>〉這篇文章最早發佈於《<a href="https://will-news.info">willnews分享應該關心的新聞</a>》。</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">6388</post-id>	</item>
		<item>
		<title>每天抽2包菸 30歲男業務「肺鱗癌」上身</title>
		<link>https://will-news.info/2019/06/06/%e6%af%8f%e5%a4%a9%e6%8a%bd2%e5%8c%85%e8%8f%b8-30%e6%ad%b2%e7%94%b7%e6%a5%ad%e5%8b%99%e3%80%8c%e8%82%ba%e9%b1%97%e7%99%8c%e3%80%8d%e4%b8%8a%e8%ba%ab/</link>
		
		<dc:creator><![CDATA[will新聞]]></dc:creator>
		<pubDate>Thu, 06 Jun 2019 08:04:16 +0000</pubDate>
				<category><![CDATA[癌症新聞]]></category>
		<category><![CDATA[肺癌]]></category>
		<category><![CDATA[鱗癌]]></category>
		<guid isPermaLink="false">https://will-news.info/2019/06/06/%e6%af%8f%e5%a4%a9%e6%8a%bd2%e5%8c%85%e8%8f%b8-30%e6%ad%b2%e7%94%b7%e6%a5%ad%e5%8b%99%e3%80%8c%e8%82%ba%e9%b1%97%e7%99%8c%e3%80%8d%e4%b8%8a%e8%ba%ab/</guid>

					<description><![CDATA[<p>年僅30多歲的男業務員，長期工作壓力大，平均每天抽1包半到2包菸，近期沒事就會突然咳嗽，症狀久久無法復原，進一步至醫院檢查，竟然罹患俗稱「肺鱗癌」的鱗狀上皮細胞肺癌，醫師表示，鱗狀上皮細胞肺癌患者平均年齡多在65歲到70歲間，鮮少發生在30歲左右的民眾身上，且大多肺鱗癌的患者79％都已轉移到其他器官，呼籲民眾應養成良好健康習慣並定期健檢。</p>
<p>〈<a href="https://will-news.info/2019/06/06/%e6%af%8f%e5%a4%a9%e6%8a%bd2%e5%8c%85%e8%8f%b8-30%e6%ad%b2%e7%94%b7%e6%a5%ad%e5%8b%99%e3%80%8c%e8%82%ba%e9%b1%97%e7%99%8c%e3%80%8d%e4%b8%8a%e8%ba%ab/">每天抽2包菸 30歲男業務「肺鱗癌」上身</a>〉這篇文章最早發佈於《<a href="https://will-news.info">willnews分享應該關心的新聞</a>》。</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">6363</post-id>	</item>
	</channel>
</rss>
